of the North Caucasus
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
русский
english
Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
Some aspects of cerebroprotective activity of 4-hydro xy-3,5-di-tretboutyle of cinnamic acid in ischemic damage of the brain in experiment
[Experimental medicine]
Andrei Voronkov; Vladimir Abaev; Eduard Oganesian; Dmitry Pozdnyakov;
Cerebroprotective properties of 4-hydroxy-3,5-di-tretboutyle cinnamic acid (ATACL) have been studied. It has been established that in the conditions of focal brain ischemia, ATACL contributes to the normalization of metabolic processes in the brain tissue: an increase in the utilization of glucose by 305.5% (p<0.02), a 281.3 % decrease in lactate formation (p<0.01), reduction of edema and necrosis zone by 5% (p<0.02) and 123.9 % (p<0.02), respectively. In this case, the effect of 4-hydroxy-3,5-di-tretboutyle cinnamic acid surpassed that of ethylmethyl hydroxypyridine succinate and thioctic acid and was comparable to the effect of Vinpocetine.
References:
1. Voronkov A. V., Pozdnyakov D. I., Mamleev A. V. Sovremennye problemy nauki i obrazovaniya. – Modern problems of science and education. 2016;2. Available at: http:// www.science-education.ru/ru/article/view?id=24398
2. Nazarova L. E., D’yakova I. N. Meditsinskiy vestnik Bashkortostana. – Medical bulletin of Bashkortostan. 2011;3:133-135.
3. Alam M. A., Subhan N., Rahman M. M. Adv. Nutrit. 2014;5:404-417. doi: 10.3945/an.113.005603
4. Cha M.-Y., Cho H. J., Kim C. Hum. Molec. Genet. 2015;24:6492-6504. doi: 10.1093/hmg/ddv358
5. Cheng Y. L., Park J. S., Manzanero S., Choi Y., Baik S. H., Okun E., Gelderblom M., Fann D. Y., Magnus T., Launikonis B. S., Mattson M. P., Sobey C. G., Jo D. G., Arumugam T. V. Neurobiol. Dis. 2014;62:286-295. doi: 10.1016/j. nbd.2013.10.009
6. Culmsee C., Monnig J., Kemp B. E., Mattson M. P. J. Mol. Neurosci. 2001;17:45-58. doi: 10.1385/JMN:17:1:45
7. Lapchak P. A. Expert Opin. Investig. Drugs. 2011;20:13- 22. doi: 10.1517/13543784.2011.542410
8. Nunez-Figueredo Y., Ramirez-Sanchez J., Hansel G. Neuropharmacology. 2014;85:517-527. doi: 10.1016/j.neuropharm. 2014.06.009
9. Rao P. V., Gan S. H. Evidence-based Complementary and Alternative Medicine : eCAM. 2014. doi:10.1155/2014/642942
10. Weisová P., Alvarez S. P., Kilbride S. M., Anilkumar U., Baumann B., Jordán J., Bernas T., Huber H. J., Düssmann H., Prehn J. H. Translational Psychiatry. 2013;10:e317. doi: 10.1038/tp.2013.92
Keywords: ischemia, cerebroprotective, derivatives of cinnamic acid
Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy